Dramatic response to rituximab in a child with severe cold autoimmune hemolytic anemia arising after allogeneic hematopoietic SCT
- 18 May 2009
- journal article
- letter
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 45 (1), 201-202
- https://doi.org/10.1038/bmt.2009.108
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Rituximab in the treatment of autoimmune haematological disordersBritish Journal of Haematology, 2008
- Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantationBone Marrow Transplantation, 2004
- Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non‐malignant diseasesBritish Journal of Haematology, 2004
- Rituximab for Immune Hemolytic Anemia following T- and B-Cell-Depleted Hematopoietic Stem Cell TransplantationActa Haematologica, 2002
- Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximabBone Marrow Transplantation, 2002
- Autoimmune hemolytic anemiaAmerican Journal of Hematology, 2002
- Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantationBone Marrow Transplantation, 2002
- Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplantBone Marrow Transplantation, 1997